In this study, we use epidermal growth factor (EGF), a key trigger in activating the EGFR signaling pathway[11]–[13], to stimulate caco-2 colon carcinoma cells which were tested to overexpress EGFR. This evidence concerns the gene EGF and colon carcinoma.